510(k) Report

510(k) · Cleared

Cleared

Crux Vena Cava Filter System

K122585510(k) SpecialCleared Jan 17, 2013146-day reviewClass II21 CFR 870.3375

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Crux Biomedical · DTK Filter, Intravascular, Cardiovascular

Cleared on Jan 17, 2013 as substantially equivalent to K120402 (Crux Biomedical, 2012) after a 146-day review. Its family tree reaches back 7 generations to 1990. 1 of the 27 devices in its family, counting itself, has a Class I recall. 1 later device descends from it.

Decided
Jan 17, 2013
Review
146 days
Class
Class II
Product code
DTK
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K901502 (1990). 25 ancestors in all. 1 later device descends from it, 1 citing it directly. 1 of the 27 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2008: 1 other ancestor2002: 2 other ancestors2000: 2 other ancestors1997: 2 other ancestors, 1 with a Class I recall11996: 1 other ancestor1995: 2 other ancestors2006: 1 other ancestor2005: 2 other ancestors1998: 1 other ancestor2003: 1 other ancestor1993: 2 other ancestors1991: 1 other ancestor2015: 1 descendant clearedK901502 · Amplatz Goose-Neck Snare · Microvena Corp. · 1990 · recalledK972511 · Amplatz Goose Neck Snare Kit/ Catheter · Microvena Corp. · 1998 · recalledK021441 · Radius Snare · Radius Medical Technologies, Inc. · 2002K022201 · Radius Micro Snare · Radius Medical Technologies, Inc. · 2003K032426 · Gunhter Tulip Vena Cava Mreye Filter and Retrieval Set · Cook, Inc. · 2003K081410 · Option Vena Cava Filter · Rex Medical · 2009K120402 · Crux Vena Cava Filter System · Crux Biomedical · 20121990200020102020
  1. Root · 7 generations backK901502 Amplatz Goose-Neck SnareMicrovena Corp. · 1990 · Recalled
  2. 6 generations backK972511 Amplatz Goose Neck Snare Kit/ CatheterMicrovena Corp. · 1998 · Recalled
  3. 5 generations backK021441 Radius SnareRadius Medical Technologies, Inc. · 2002
  4. 4 generations backK022201 Radius Micro SnareRadius Medical Technologies, Inc. · 2003
  5. 3 generations backK032426 Gunhter Tulip Vena Cava Mreye Filter and Retrieval SetCook, Inc. · 2003
  6. 2 generations backK081410 Option Vena Cava FilterRex Medical · 2009
  7. 1 generation backK120402 Crux Vena Cava Filter SystemCrux Biomedical · 2012
  8. This deviceK122585 Crux Vena Cava Filter SystemCrux Biomedical · 2013
  9. Descendant · cites it directly · 0 of its ownK150262 Crux Vena Cava Filter System, femoral; Crux Vena Cava Filter System…Volcano Corporation · 2015

Class I recalls in this family

Most influential descendants

Showing 1 of 1 · See all
  • K150262Crux Vena Cava Filter System, femoral; Crux Vena Cava Filter System, jugularVolcano Corporation · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K901502Amplatz Goose-Neck SnareMicrovena Corp.19901
−6K972511Amplatz Goose Neck Snare Kit/ CatheterMicrovena Corp.19981
−5K021441Radius SnareRadius Medical Technologies, Inc.2002—
−4K022201Radius Micro SnareRadius Medical Technologies, Inc.2003—
−3K032426Gunhter Tulip Vena Cava Mreye Filter and Retrieval SetCook, Inc.2003—
−2K081410Option Vena Cava FilterRex Medical2009—
−1K120402Crux Vena Cava Filter SystemCrux Biomedical2012—
0 (this device)K122585Crux Vena Cava Filter SystemCrux Biomedical2013—
+1K150262Crux Vena Cava Filter System, femoral; Crux Vena Cava Filter System, jugularVolcano Corporation2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199320
199520
199610
199721
199810
200020
200220
200310
200520
200610
200810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
FIG. 1 — Lineage of K122585, 1990–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DTK device

  1. #1 K242612 Option ELITE Vena Cava Filter System…score 10.1 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120402Crux Vena Cava Filter System
Summary page 1
…K I120402/S I and S2 Numbers: Device Proprietary Name: Crux Vena Cava Filter System Basis of Submission: Special 5 10(k) based on K 120402 Crux Vena Cava Filter System consists of:- Kit Description: Crux Vena C…
Crux Biomedical2012—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K150262Crux Vena Cava Filter System, femoral; Crux Vena Cava Filter System, jugularVolcano Corporation20150

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K970466Radius Ptca GuidewireRadius Medical Technologies, Inc. · 1997 · 5 generations back · ◆ in the 1997 ancestors bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 23 years and passes through 5 companies; a new generation was cleared every 3.1 years on median.
  • 5 of the 25 ancestors have a recall of any class; 1 has a Class I recall.
  • Of its descendants, K150262 (Volcano Corporation, 2015) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DTK devices

DTK Filter, Intravascular, Cardiovascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · DTK

5in 2024

2007: 32008: 62009: 32010: 32011: 22012: 52013: 32014: 22015: 22016: 32017: 52018: 22021: 22024: 5
2007high 6 (2008) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DTK

29in 2024

2007: 87 days median2008: 87 days median2009: 380 days median2010: 50 days median2012: 156 days median2013: 91 days median2016: 84 days median2017: 88 days median2024: 29 days median
2007high 380 (2009) · low 29 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DTK

1in 2025

2007: 12013: 12015: 12016: 22019: 62022: 22025: 1
2007high 6 (2019) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DTK

432in 2025

2007: 3642008: 3452009: 4562010: 3692011: 4392012: 3512013: 4732014: 4512015: 8592016: 2,5742017: 4,3642018: 3,9382019: 6,4672020: 5,4052021: 5,3572022: 2,1912023: 5832024: 4062025: 432
2007high 6,467 (2019) · low 345 (2008)2025

MAUDE reports naming product code DTK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20073871364
20086870345
200933800456
20103500369
20112—0439
201251560351
20133911473
20142—0451
20152—1859
201638422,574
201758804,364
20182—03,938
20190—66,467
20200—05,405
20212—05,357
20220—22,191
20230—0583
20245290406
20250—1432
20260—0—

What is it indicated for?

The Crux VCF System is indicated for the prevention of recurrent pulmonary embolism via placement in the inferior vena cava (IVC) in the following situations: * Pulmonary thromboembolism when anticoagulants are contraindicated, * Failure of anticoagulant therapy in thromboembolic diseases, * Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced, * Chronic, recurrent pulmonary embolism…

Read the full statement (110 words)

The Crux VCF System is indicated for the prevention of recurrent pulmonary embolism via placement in the inferior vena cava (IVC) in the following situations:

* Pulmonary thromboembolism when anticoagulants are contraindicated,

* Failure of anticoagulant therapy in thromboembolic diseases,

* Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced,

* Chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated.

The Crux VCF may be removed according to the instructions contained in the section "Optional Retrieval of the Crux VCF" in patients who no longer require a vena cava filter. Retrieval of the filter can be performed by femoral or jugular approach.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K122585: Crux Vena Cava Filter System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K122585

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026